MarketBeat provided average ratings and consensus target prices for Pacira BioSciences, while Needham and Royal Bank of Canada issued rating updates.
10 reports, 2 independent
Updated Sun 00:00
Still developing
- Reports
- 10
- Developments
- 2
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided average ratings and consensus target prices for Pacira BioSciences, while Needham and Royal Bank of Canada issued rating updates.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.RBC boosted Pacira's price target while Jefferies lowered its rating.1 source
Needham and RBC raised price targets and gave buy ratings for Pacira BioSciences.1 source
Keep exploring
The entities involved
-
Needham & Company
American independent investment bank and asset management firm
-
Royal Bank of Canada
financial institution in Canada
Related events
- MarketBeat provided consensus ratings for MACOM as Susquehanna dropped its price objective and Needham & Company increased its target and gave a buy rating.
- MarketBeat is providing average rating data as Royal Bank of Canada issues a price target report regarding ConocoPhillips.
- Royal Bank of Canada reaffirmed an outperform rating for Visa Inc., with average rating data provided by MarketBeat.
- MarketBeat reported average rating and target price, following Royal Bank of Canada initiating coverage on Ur Energy Inc.
- Royal Bank of Canada reiterated a sector perform rating for Lucid Group, Inc., with MarketBeat providing average rating and price target.